| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/20/2009 | US20090210034 System and Method for Monitoring Power Source Longevity of an Implantable Medical Device |
| 08/20/2009 | US20090209937 Apparatus and Methods for Treating Epilepsy Using Convection-Enhanced Delivery |
| 08/20/2009 | US20090209905 Compositions comprising chitin microparticles and their medical uses |
| 08/20/2009 | US20090209747 Method to inhibit cell growth using oligonucleotides |
| 08/20/2009 | US20090209639 Process for modifying drug crystal formation |
| 08/20/2009 | US20090209037 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/20/2009 | US20090208586 porous bioabsorbable material and method of producing the same |
| 08/20/2009 | US20090208585 Stabilisation of biological materials |
| 08/20/2009 | US20090208584 Solid preparation |
| 08/20/2009 | US20090208583 Tablets comprising candesartan cilexetil |
| 08/20/2009 | US20090208582 Templated Open Flocs of Anisotropic Particles for Enhanced Pulmonary Delivery |
| 08/20/2009 | US20090208581 Formulations limiting spread of pulmonary infections |
| 08/20/2009 | US20090208580 Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles |
| 08/20/2009 | US20090208579 Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
| 08/20/2009 | US20090208578 Method of tissue repair using a multi-layered matrix |
| 08/20/2009 | US20090208577 Inkjet Printing of Tissues and Cells |
| 08/20/2009 | US20090208576 Orally Disintegrating Tablets |
| 08/20/2009 | US20090208575 Pharmaceutical Composition Of Acid Labile Substances |
| 08/20/2009 | US20090208574 Dip coated compositions containing a starch having a high amylose content |
| 08/20/2009 | US20090208573 Novel polymorph form of irbesartan |
| 08/20/2009 | US20090208572 Oral controlled release tablet |
| 08/20/2009 | US20090208571 Dosage form containing pantoprazole as active ingredient |
| 08/20/2009 | US20090208570 Extended Release Dosage forms of Metoprolol |
| 08/20/2009 | US20090208569 Homogeneous, Thermoreversible Alginate Films and Soft Capsules Made Therefrom |
| 08/20/2009 | US20090208568 Gellan Seamless Breakable Capsule and Process for Manufacturing Thereof |
| 08/20/2009 | US20090208567 Substance-containing carbon nanohorn composite having polyamine plug and process for producing the same |
| 08/20/2009 | US20090208566 Capsules Containing Seminal Material for Artificial Insemination |
| 08/20/2009 | US20090208565 Stabilized exendin-4 compounds |
| 08/20/2009 | US20090208564 Compositions of asymmetric interfering RNA and uses thereof |
| 08/20/2009 | US20090208563 Method for delivering genes |
| 08/20/2009 | US20090208562 Vaccine Composition Comprising a Fibronectin Binding Protein or a Fibronectin Binding Peptide |
| 08/20/2009 | US20090208561 Transdermal therapeutic system |
| 08/20/2009 | US20090208560 Cover material and plaster with cover material |
| 08/20/2009 | US20090208559 Device for delivering active ingredients to humans, animals and plants |
| 08/20/2009 | US20090208558 Use of Combination Preparations Comprising Antifungal Agents |
| 08/20/2009 | US20090208555 Control of the degradation of biodegradable implants using a coating |
| 08/20/2009 | US20090208552 Cross-linked fatty acid-based biomaterials |
| 08/20/2009 | US20090208551 Biological implantation material and method for preparing same |
| 08/20/2009 | US20090208550 Methods and compositions for treating hepatic diseases |
| 08/20/2009 | US20090208548 Copolymer-stabilized emulsions |
| 08/20/2009 | US20090208546 Aqueous coating compositions |
| 08/20/2009 | US20090208545 System and method for providing medicinal treatment |
| 08/20/2009 | US20090208540 Implantable device for the delivery of naltrexone and methods of use thereof |
| 08/20/2009 | US20090208539 Stable atorvastatin formulations |
| 08/20/2009 | US20090208425 Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone |
| 08/20/2009 | US20090208424 Compositions and methods for delivery of solution to the skin |
| 08/20/2009 | US20090208422 Composition for improving efficiency of drug delivery |
| 08/20/2009 | DE112007001799T5 Liposomale Antioxidantien-Zusammensetzung zur Inhalation bei Erkrankungen der Lunge und der oberen Atemwege Antioxidants liposomal composition for inhalation in diseases of the lungs and upper respiratory tract |
| 08/20/2009 | DE112006004066T5 Magnetischer Träger und medizinisches Präparat zur kontrollierbaren Zuführung und Freisetzung von Wirkstoffen, Herstellungsverfahren dafür und Behandlungsverfahren unter Verwendung davon The magnetic carrier, and medical preparation for controllably supplying and release of active substances, processes for its preparation and methods of treatment using them |
| 08/20/2009 | DE102008005673A1 Bläschen, sowie Verfahren zur Herstellung und Manipulation von Bläschen Vesicles, and methods for preparing and manipulating bubbles |
| 08/20/2009 | CA2726861A1 Devices, formulations, and methods for delivery of multiple beneficial agents |
| 08/20/2009 | CA2723314A1 Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
| 08/20/2009 | CA2715640A1 Wettable fillers for improved release of hydrophilic materials from chewing gum compositions |
| 08/20/2009 | CA2715379A1 Formulation and method for the prevention and treatment of skeletal manifestation of gaucher's disease |
| 08/20/2009 | CA2715133A1 Fine powder of polyamide from renewable materials and method for making such powder |
| 08/20/2009 | CA2715059A1 Adhesive patch systems and methods |
| 08/20/2009 | CA2714598A1 Drug delivery system with stabilising effect |
| 08/20/2009 | CA2714542A1 Formulations of flibanserin |
| 08/20/2009 | CA2714524A1 Tablet having improved elution properties |
| 08/20/2009 | CA2714340A1 Estradiol-containing drug delivery system |
| 08/20/2009 | CA2712832A1 Implantable products comprising nanoparticles |
| 08/20/2009 | CA2711592A1 Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials |
| 08/20/2009 | CA2703866A1 Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
| 08/19/2009 | EP2090589A1 Albumin-fused Kunitz domain peptides |
| 08/19/2009 | EP2090358A1 Method for production of microcapsule |
| 08/19/2009 | EP2090314A1 Ophthalmic aqeous liquid preparation |
| 08/19/2009 | EP2090310A1 Method for prevention of coloration in donepezil-containing skin adhesive preparation, and method for reducing the production of donepezil analogue in donepezil-containing skin adhesive preparation |
| 08/19/2009 | EP2090308A1 Pharmaceutical composition for the treatment or prevention of osteoarticular diseases |
| 08/19/2009 | EP2090307A1 Pharmaceutical composition for the treatment or prevention of osteoarticular diseases |
| 08/19/2009 | EP2090305A1 Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome |
| 08/19/2009 | EP2090300A1 Sustained release preparation |
| 08/19/2009 | EP2090299A2 Extended Release Gliclazide Formulations |
| 08/19/2009 | EP2090298A1 Method for production of sustained release tablet |
| 08/19/2009 | EP2090297A1 Formulations of flibanserin |
| 08/19/2009 | EP2090296A2 Application of agent complexes composed of panthenol, glycerin, citrate and/or bisabal oil against pollen allergy |
| 08/19/2009 | EP2090165A2 Antifungal composition with enhanced bioavailability |
| 08/19/2009 | EP2089060A1 Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| 08/19/2009 | EP2089045A2 Use of il-27 antagonists for the manufacture of a medicament for the treatment of aplastic anemia |
| 08/19/2009 | EP2089043A2 Method for the production of an agent against an infectious disease |
| 08/19/2009 | EP2089034A1 Novel uses |
| 08/19/2009 | EP2089010A1 Rapid release mini-tablets provide analgesia in laboratory animals |
| 08/19/2009 | EP2089008A2 Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser |
| 08/19/2009 | EP2089007A2 Transdermal delivery of ketoprofen polar derivatives |
| 08/19/2009 | EP2089006A2 Medicament with controlled release containing galanthamine |
| 08/19/2009 | EP2089005A2 Layered pharmaceutical formulations comprising an intermediate rapidly dissolving layer |
| 08/19/2009 | EP2089004A1 Solid dosage form with a film containing an active substance, as well as its method of production |
| 08/19/2009 | EP2089003A1 Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
| 08/19/2009 | EP2089002A1 Phenylalkyl carbamate compositions |
| 08/19/2009 | EP2089001A2 High protein concentration formulations containing mannitol |
| 08/19/2009 | EP2089000A2 Injectable depot composition and its process of preparation |
| 08/19/2009 | EP2088999A1 Pharmaceutical composition comprising an active ingredient which neutralizes and/or binds gastric acid, such as an alginic acid derivative |
| 08/19/2009 | EP2088998A2 Unit dosage package and methods for administering weight loss medications |
| 08/19/2009 | EP2088997A1 Liquid anti-rabies antibody formulations |
| 08/19/2009 | EP2088996A1 Liquid pharmaceutical compositions comprising a bisphosphonate compound |
| 08/19/2009 | EP1957049B1 Granular, gastro-resistant product based on niacin or derivates thereof and process for the production of such a product |
| 08/19/2009 | EP1912686B1 Coiled wire for the controlled release of dugs to the eye |
| 08/19/2009 | EP1853232B1 Stable crystalline form of bifeprunox mesylate, dosage forms thereof adn methods for using them |
| 08/19/2009 | EP1696923B1 Nicotine delivery product and method for producing |
| 08/19/2009 | EP1663171B9 Heterofunctional copolymers of glycerol and polyethylene glycol, their conjugates and compositions |
| 08/19/2009 | EP1556006A4 Water soluble sheet composition |